CoreWeaveCRWV

Business Snapshot

• CoreWeave, Inc. Class A Common Stock (NASDAQ: CRWV) is a US-listed common stock, listed on March 28, 2025.
• The payload provides no sector classification or detailed business description. Financially, the company shows a capital-intensive operating profile: rapidly expanding assets, substantial financing activity, very large capital expenditures, and negative free cash flow.
• Current price: $89.36. The session range is unusually wide at $60.55–$138.25, indicating substantial volatility.
• The stock has gained 20.03% across the 200 daily bars in the supplied dataset, but the current price remains below its 20-day and 200-day moving averages.

Financial Trends

• Revenue trajectory: Revenue increased from $1.365 billion in 2025-09-30 to $5.131 billion in 2025-12-31, then declined to $2.078 billion in 2026-03-31, before rising to $2.575 billion in 2026-06-30. The latest quarter increased $497 million, or 23.9%, quarter over quarter, while remaining $1.206 billion, or 23.5%, above the 2025-09-30 level. The trajectory is volatile rather than consistently accelerating.
• Operating profitability: Operating income moved from +$51.85 million in 2025-09-30 to -$46 million in 2025-12-31, -$144 million in 2026-03-31, and -$49 million in 2026-06-30. The latest quarter improved by $95 million versus Q1 2026, and operating margin improved from -6.93% to -1.90%, but it remained negative and below the earlier +3.80% margin.
• Net income and margins: Net losses were $110.1 million, $1.167 billion, $740 million, and $626 million across the four periods from oldest to latest. The latest net loss narrowed by $114 million, or 15.4%, quarter over quarter, and net margin improved from -35.61% to -24.31%. However, net margin remains materially worse than the -8.07% level in 2025-09-30.
• Share count and EPS: Diluted weighted-average shares increased from 497.9 million in 2025-09-30 to 551 million in 2026-06-30, a rise of approximately 53.1 million, or 10.7%. Diluted EPS improved from -$1.40 to -$1.14 sequentially but remains negative.
• Free cash flow: FCF was negative in every supplied period: -$4.750 billion, -$7.251 billion, -$4.711 billion, and -$10.454 billion from oldest to latest. Latest FCF deteriorated by $5.743 billion, or 122%, quarter over quarter, and by $5.704 billion, or 120%, versus 2025-09-30. This is the clearest negative inflection in the financial data.
• Cash flow and capital expenditure: Operating cash flow rose from $1.499 billion in 2025-09-30 to $3.663 billion in the latest period, an increase of $2.164 billion, or 144%. However, capital expenditures expanded from $6.249 billion to $14.117 billion, up $7.868 billion, or 126%, causing FCF to worsen substantially. Investing cash outflows also increased from $6.345 billion to $14.874 billion.
• Assets and liabilities: Total assets increased from $32.910 billion to $77.070 billion, up $44.160 billion, or 134% across the four periods. Total liabilities increased from $29.032 billion to $72.046 billion, up $43.014 billion, or 148%. Liabilities therefore grew faster than assets.
• Liquidity and working capital: Cash increased from $1.894 billion to $5.524 billion, but current liabilities rose from $9.715 billion to $20.917 billion, while current assets reached $9.520 billion. The current ratio was 0.49 initially and 0.46 most recently, after reaching 0.31 in 2026-03-31. Working capital deteriorated from -$4.984 billion to -$11.397 billion, a worsening of $6.413 billion.
• Equity and retained earnings: Shareholders’ equity increased from $3.878 billion to $5.024 billion, but retained earnings became more negative, moving from -$2.192 billion to -$4.009 billion. This reflects continuing accumulated losses despite the increase in reported equity.
• Debt: Reported long-term debt rose from $10.323 billion in 2025-09-30 to $14.665 billion at year-end and $17.312 billion in 2026-03-31. The latest table reports long-term debt as unavailable, so the latest debt trajectory cannot be fully determined. Debt/equity increased from 2.66 to 4.40 before improving to 3.64 in 2026-03-31; the latest ratio is unavailable.

Financial Health

• The latest period shows improving revenue and operating performance sequentially, but not yet a clean profitability inflection. Revenue rose 23.9% quarter over quarter, operating losses narrowed, and operating margin improved to -1.90%.
• The principal financial risk is funding the expansion. Latest FCF was -$10.454 billion, versus $3.663 billion of operating cash flow, because capital expenditures reached $14.117 billion.
• Liquidity remains strained on the supplied balance sheet. The latest current ratio is 0.46, current liabilities exceed current assets by $11.397 billion, and liabilities represent approximately 93.5% of total assets.
• Cash increased by $3.280 billion from 2025-09-30 to 2026-06-30, but the cash balance is small relative to the latest quarterly investing outflow and capital-expenditure figures. Financing inflows of $13.985 billion in the latest period materially supported cash generation.
• The balance sheet is expanding rapidly, but leverage and accumulated losses are also significant. The missing latest long-term-debt figure prevents a complete assessment of current leverage.
• Overall, the latest data supports a high-growth, high-capital-intensity profile with improving operating losses but worsening free-cash-flow requirements.

Insider Activity

• Insider sentiment for June 9 through September 7, 2026 is Neutral (-10), but the transaction value is heavily skewed toward selling: $90.204 million of sales across 55 transactions versus only $85,800 of purchases in one transaction.
• Net insider activity was -$90.119 million.
• Several large sales occurred around $81–$90 per share, including substantial transactions by Michael N. Intrator and Kristen J. McVeety. The dataset also contains paired buy/sell or non-monetary entries, so not every reported line necessarily represents an outright open-market purchase or sale.
• Even with that caveat, the aggregate dollar imbalance is a negative signal: disclosed selling substantially exceeded disclosed buying during the period.
• Insider data should be treated as a sentiment and supply consideration, not as a standalone timing signal; the filings do not establish the sellers’ reasons.

Multi-Timeframe Technical Context

• Ultra-short horizon — minutes: No intraday candle or indicator data was provided, and the market status is holiday. A minute-by-minute setup therefore cannot be confirmed. The very wide supplied session range of $60.55–$138.25 indicates that liquidity and price discovery may be highly unstable when trading is active.
• Short horizon — hours to days: Daily RSI-14 is 28.33, placing it in oversold territory, while RSI-21 is 52.92, showing a materially less weak reading over the longer lookback. This divergence suggests a recent short-term selloff within a broader, less clearly oversold trend.
• Price at $89.36 is above the 12-day EMA of $86.65, the 26-day EMA of $87.58, and the 50-day SMA of $85.62, but below the 20-day SMA of $91.02 and 200-day SMA of $91.47.
• MACD is -0.9311 versus a signal line of -0.2231, a bearish configuration. The price’s position above several shorter moving averages therefore has not yet been confirmed by momentum.
• The Bollinger Band range is $74.24–$107.79, with a middle band at $91.02. At $89.36, price is below the middle band but well above the lower band.
• ATR is $5.03, implying a large expected daily trading range relative to the share price. The 20-day average volume is 27.24 million, versus current supplied volume of 20.80 million, or approximately 76% of average.
• Longer horizon — weeks to months: The 200-bar price performance is positive at +20.03%, but price remains below both the 20-day and 200-day averages, and MACD remains negative. The longer-term technical picture is therefore mixed: positive cumulative performance, but current trend confirmation is lacking.

Bull / Bear Cases

• Short-term bull case:
  • RSI-14 at 28.33 supports the possibility of an oversold rebound.
  • Price is above the 12-day EMA, 26-day EMA, and 50-day SMA, with nearby support clustered around $85.62–$87.58.
  • Revenue grew 23.9% sequentially, while operating losses narrowed by $95 million, providing a fundamental backdrop for a recovery if buyers reclaim the nearby moving-average resistance.
• Short-term bear case:
  • MACD remains bearish, with -0.9311 below -0.2231.
  • Price is below the $91.02 20-day SMA and $91.47 200-day SMA, creating an overhead resistance zone.
  • ATR of $5.03 and the supplied session range show elevated volatility; a break below the mid-$80s could expose the lower Bollinger area near $74.24.
  • Recent insider activity is strongly sell-dominated by dollar value.
• Long-term bull case:
  • Revenue is materially higher than four periods ago, up $1.206 billion, or 88.4%, from 2025-09-30.
  • Operating cash flow increased 144% over the same period, and the latest operating loss narrowed sharply from the prior quarter.
  • If revenue growth eventually outpaces infrastructure spending, the current expansion could produce operating leverage and improve profitability.
• Long-term bear case:
  • FCF deteriorated to -$10.454 billion, more than twice as negative as the 2025-09-30 figure.
  • Capital expenditures increased 126% across the four periods, while total liabilities grew 148%, faster than total assets.
  • The latest current ratio of 0.46, negative working capital of $11.397 billion, negative retained earnings of $4.009 billion, and ongoing net losses point to substantial financing and execution risk.
  • Diluted shares increased 10.7% over the four periods, creating potential dilution pressure for existing shareholders.
  • The latest long-term-debt figure is missing, limiting visibility into the current leverage burden.

Key Levels & Triggers

• Current reference price: $89.36.
• Near-term support: The 26-day EMA at $87.58, 12-day EMA at $86.65, and 50-day SMA at $85.62 form a nearby technical support band.
• Near-term resistance: The 20-day SMA at $91.02 and 200-day SMA at $91.47 form the first important overhead zone. A sustained move above this area would improve short-term trend confirmation.
• Volatility reference: ATR is $5.03; moves of several dollars per day should be considered normal for this dataset.
• Downside trigger: A decisive break below the $85.62–$87.58 support band would weaken the rebound setup and could shift focus toward the lower Bollinger Band at $74.24.
• Upside trigger: Reclaiming and holding $91.02–$91.47, ideally with stronger-than-average volume, would improve the technical structure. Current volume is below the 20-day average, so confirmation is not yet present.
• Fundamental triggers to monitor: sequential revenue growth, operating-margin improvement toward positive territory, reduction in quarterly capital expenditure, FCF improvement from -$10.454 billion, and updated debt data.
• Risk trigger: Continued reliance on large financing inflows alongside expanding capital expenditures and negative FCF would reinforce the long-term balance-sheet risk.